Propulsid

Do I have a case?

 

What is Propulsid?

What is the problem?

Who is responsible?

What is being done?

What can you do?

FAQs

Breaking news

Resources on the web

Medical information

 

What is the Problem?

After several years of availability, it now seems that Propulsid has inherited the same problems as its predecessor. The best illustration of the problems with Propulsid can be made with statistics. Since its approval by the FDA, there have been over 340 reports of heart rhythm abnormalities in patients prescribed with Propulsid. Of these, at least 80 cases have resulted in deaths.

It took two years from the approval of Propulsid for warning labels to begin appearing on the containers. The World Health Organization had identified problems with Cisapride as early as 1989. The research team had identified a distraction in the electrical activity of the heart. However, it was not until February 1995 when Janssen Pharmaceutica finally provided warning labeling on its products. There was nothing to warn patients or doctors that what they thought was simply a cure for heartburn could in fact cause death.

The FDA recognized that there may be some minor adverse effects associated with Propulsid when it was approved. These effects were thought to be fairly standard and by no means dangerous or life threatening. From then on, however, a number of new side-effects were discovered and subsequently added to the Propulsid label. Such possibilities included: sudden cardiac death, heart attack, irregular heartbeat and QT interval prolongation.

The problem with Propulsid does not end here.
It would be safe to assume that a drug that already had proven side-effects, plus a main constituent that had already been the cause of major side-effects, would only be available to adults. Indeed, the official FDA approval only covered adults, and the official statement on such situations is that Propulsid was only ever approved for use by adults. However, many children and premature babies were administered Propulsid to treat colic. Considering that the product was not even approved for use on children, the proportion of the deaths that were children is somewhat astonishing. Of the 80 reported deaths on record at the FDA, 11 were children. There were also another 20 children that survived Propulsid-related heart irregularities.

A combination of drugs can cause Propulsid to become more dangerous. However, this is not all. A certain number of other illnesses, when combined with Gastro Intestinal Reflux Disease, can have a similar effect.

 


 

Do I have a Propulsid Case?

 

 

 


 

 Email this page to a friend.

 

Home  |  Site Map  |  Blogs  | Disclaimer  |  Do I Have A case

© 2002-2008 All Rights Reserved Monheit Law. 

 

AddThis Social Bookmark Button